AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,555,000 | +145.7% | 220,400 | +45.6% | 2.34% | +115.0% |
| Q2 2017 | $633,000 | -76.8% | 151,330 | -56.2% | 1.09% | -69.6% |
| Q1 2017 | $2,724,000 | -24.7% | 345,177 | -27.2% | 3.59% | -13.7% |
| Q4 2016 | $3,619,000 | +9.0% | 474,240 | +18.2% | 4.16% | +57.9% |
| Q3 2016 | $3,321,000 | +19.6% | 401,118 | -10.3% | 2.63% | +10.4% |
| Q2 2016 | $2,776,000 | -22.5% | 447,276 | -28.3% | 2.38% | -36.4% |
| Q1 2016 | $3,580,000 | +653.7% | 624,019 | +1329.4% | 3.75% | +971.4% |
| Q4 2015 | $475,000 | – | 43,656 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
| DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
| Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
| Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
| Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
| Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
| Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
| Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
| KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
| Leap Investments LP | 54,700 | $415,000 | 0.61% |